For instance, Dennler et al. (2007) demonstrated that pharmacologic blockade of TGF-β signaling in SMOi-resistant PDAC cells expressing high levels of GLI, reduces GLI2 expression with a subsequent repression of cancer cell proliferation. Here, TGFB1 is linked to cancer.